MicroRNA expression profiling in diabetic GK rat model

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 6, 2009, Pages 472-477

  Huang, Bing ^a   Qin, Wenming ^a   Zhao, Botao ^a   Shi, Yi ^a   Yao, Chengguo ^a   Li, Jin ^b   Xiao, Huasheng ^c   Jin, Youxin ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b St Luke's Hospital   (China)

^c NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI   (China)

Author keywords

Diabetes; GK (Goto Kakizaki) rat; MicroRNA; P38 MAPK; Wistar rat

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

MICRORNA;

ANIMAL; ARTICLE; DISEASE MODEL; DNA MICROARRAY; DNA PROBE; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION PROFILING; GENETICS; NUCLEOTIDE SEQUENCE; RAT; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DNA PROBES; GENE EXPRESSION PROFILING; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR;

EID: 68549127123     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp035     Document Type: Article

References (26)

1. American Diabetes Association. Clinical Practice Recommendations 2001. Diabetes Care 2001 24: S1-S133.
2. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R and Hollenbeck A, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006, 355: 763-778.
3. Akerblom H. Pathogenesis of Type 1 diabetes: Environmental factors. In: Turtle J, Kaneko T and Osato S eds. Diabetes in the New Millennium. Sydney: Endocrinology and Diabetes Research Foundation, University of Sydney, 1999.
4. Kahn SE. Clinical review 135: The importance of b-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001, 86: 4047-4058.
5. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM and Patel HR, et al. The hormone resistin links obesity to diabetes. Nature 2001, 409: 307-312.
6. Portha B. Programmed disorders of b-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev 2005, 21: 495-504.
7. Hao J, Shen W, Tian C, Liu Z, Ren J, Luo C and Long J, et al. Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats. J Cell Mol Med 2008; doi:10.1111/ j.1582-4934.2008.00342.x.
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281-297.
9. Kato M and Slack FJ. MicroRNAs: Small molecules with big roles- C. elegan to human cancer. Biol Cell 2008, 100: 71-81.
10. Scalbert E and Bril A. Implication of microRNAs in the cardiovascular system. Curr Opin Pharmacol 2008, 8: 181-188.
11. Barbarotto E, Schmittgen TD and Calin GA. MicroRNAs and cancer: Profile, profile, profile. Int J Cancer 2008, 122: 969-977.
12. Poy MN, Spranger M and Stoffel M. MicroRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab 2007, 2: S67-S73.
13. Zhao B, Liang R, Ge L, Li W, Xiao H, Lin H and Ruan K, et al. Identification of drought-induced microRNAs in rice. Biochem Biophys Res Commun 2007, 354: 585-590.
14. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A and Enright AJ. miRBase: MicroRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34(Database Issue): D140-D144.
15. Liang RQ, Li W, Li Y, Tan CY, Li JX, Jin YX and Ruan KC. An oligonucleotide microarray for microRNA expression analysis based on labeling RNA with quantum dot and nanogold probe. Nucleic Acids Res 2005, 33: Pe17.
16. Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioukos C, Mourelatos Z and Hatzigeorgiou A. A combined computationalexperimental approach predicts human microRNA targets. Genes Dev 2004, 18: 1165-1178.
17. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE and Pfeffer S, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432: 226-230.
18. He A, Zhu L, Gupta N, Chang Y and Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 2007, 21: 2785-2794.
19. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ and Davuluri R, et al. A microRNA signature of hypoxia. Mol Cell Biol 2007, 27: 1859-1867.
20. Marsit CJ, Eddy K and Kelsey KT. MicroRNA responses to cellular stress. Cancer Res 2006, 66: 10843-10848.
21. Sarafidis PA and Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: Mechanisms and implications. Am J Nephrol 2006, 26: 232-244.
22. Sun Q, Zhang Y, Yang G, Chen X, Zhang Y, Cao G and Wang J, et al. Transforming growth factor-b-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res 2008, 36: 2690-2699.
23. Xu ZG, Yuan H, Lanting L, Li SL, Wang M, Shanmugam N and Kato M, et al. Products of 12/15-lipoxygenase upregulate the angiotensin II receptor. J Am Soc Nephrol 2008, 19: 559-569.
24. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T and Kuboki K, et al. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 1999, 103: 185-195.
25. Susztak K, Raff AC, Schiffer M and Böttinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.Diabetes 2006, 55: 225-233.
26. Imai G, Satoh T, Kumai T, Murao M, Tsuchida H, Shima Y and Ogimoto G, et al. Hypertension accelerates diabetic nephropathy in Wistar fatty rats, a model of type 2 diabetes mellitus, via mitogenactivated protein kinase cascades and transforming growth factor-b1. Hypertens Res 2003, 26: 339-347.